Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression
Open Access
- 1 May 2013
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 288 (20), 14510-14521
- https://doi.org/10.1074/jbc.m113.458737
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300Cancer Research, 2013
- The HAT/HDAC interplay: Multilevel control of STAT signalingCytokine & Growth Factor Reviews, 2012
- Phosphorylation-Dependent Protein-Protein Interaction Modules As Potential Molecular Targets for Cancer TherapyCurrent Drug Targets, 2012
- Histone deacetylase inhibitors in the treatment of cancer: overview and perspectivesFuture Medicinal Chemistry, 2012
- Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cellsCellular Signalling, 2012
- Cellular Inhibitor of Apoptosis Protein-1 (cIAP1) Can Regulate E2F1 Transcription Factor-mediated Control of Cyclin TranscriptionOnline Journal of Public Health Informatics, 2011
- Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell CarcinomaCancer Research, 2011
- A Cell-Based High-Throughput Assay for the Screening of Small-Molecule Inhibitors of p53–MDM2 InteractionSLAS Discovery, 2011
- Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer ProgressionClinical Cancer Research, 2009
- Mutations and Deletions of the CBP Gene in Human Lung CancerClinical Cancer Research, 2005